Aromas And Chemicals Therapeutics Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 1.00 M
- Company Age 2 Year, 6 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth 510.36%
- Profit Growth 1044.03%
- Ebitda 922.26%
- Net Worth 61.23%
- Total Assets 126.56%
About Aromas And Chemicals Therapeutics
Aromas And Chemicals Therapeutics Private Limited (AACTPL) is a Private Limited Indian Non-Government Company incorporated in India on 02 August 2022 (Two years and six months 25 days old ). Its registered office is in Hyderabad, Telangana, India.
The Company is engaged in the Agriculture Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 1.00 M, as per Ministry of Corporate Affairs (MCA) records.
Ashok Billa and Divya Billa serve as directors at the Company.
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24290TG2022PTC165378
- Company No.
165378
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
02 Aug 2022
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Who are the key members and board of directors at Aromas And Chemicals Therapeutics?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ashok Billa  | Director | 02-Aug-2022 | Current |
| Divya Billa | Director | 29-Nov-2023 | Current |
Financial Performance of Aromas And Chemicals Therapeutics.
Aromas And Chemicals Therapeutics Private Limited, for the financial year ended 2024, experienced significant growth in revenue, with a 510.36% increase. The company also saw a substantial improvement in profitability, with a 1044.03% increase in profit. The company's net worth Soared by an impressive increase of 61.23%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Aromas And Chemicals Therapeutics?
Unlock access to Aromas And Chemicals Therapeutics's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Aromas And Chemicals Therapeutics?
Aromas And Chemicals Therapeutics has a workforce of 0 employees as of Jan 30, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Aromas And Chemicals Therapeutics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Aromas And Chemicals Therapeutics's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
